Gain Therapeutics, Inc. (GANX)

Gain Therapeutics Statistics

Total Valuation

GANX has a market cap or net worth of $78.15 million. The enterprise value is $58.04 million.

Market Cap	78.15M
Enterprise Value	58.04M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, before market open.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

GANX has 42.24 million shares outstanding. The number of shares has increased by 44.08% in one year.

Current Share Class	42.24M
Shares Outstanding	42.24M
Shares Change (YoY)	+44.08%
Shares Change (QoQ)	+8.06%
Owned by Insiders (%)	3.17%
Owned by Institutions (%)	19.30%
Float	40.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.19
P/TBV Ratio	4.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.63, with a Debt / Equity ratio of 0.04.

Current Ratio	6.63
Quick Ratio	6.46
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -155.66% and return on invested capital (ROIC) is -85.80%.

Return on Equity (ROE)	-155.66%
Return on Assets (ROA)	-67.01%
Return on Invested Capital (ROIC)	-85.80%
Return on Capital Employed (ROCE)	-96.22%
Weighted Average Cost of Capital (WACC)	4.82%
Revenue Per Employee	n/a
Profits Per Employee	-$806,444
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, GANX has paid $861,118 in taxes.

Income Tax	861,118
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.21% in the last 52 weeks. The beta is 0.11, so GANX's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	+2.21%
50-Day Moving Average	2.13
200-Day Moving Average	2.16
Relative Strength Index (RSI)	40.36
Average Volume (20 Days)	834,197

Short Selling Information

The latest short interest is 2.87 million, so 6.80% of the outstanding shares have been sold short.

Short Interest	2.87M
Short Previous Month	2.88M
Short % of Shares Out	6.80%
Short % of Float	7.03%
Short Ratio (days to cover)	3.55

Income Statement

Revenue	n/a
Gross Profit	-10.07M
Operating Income	-18.73M
Pretax Income	-19.30M
Net Income	-20.16M
EBITDA	-18.69M
EBIT	-18.73M
Earnings Per Share (EPS)	-$0.61

Balance Sheet

The company has $20.84 million in cash and $732,067 in debt, with a net cash position of $20.11 million or $0.48 per share.

Cash & Cash Equivalents	20.84M
Total Debt	732,067
Net Cash	20.11M
Net Cash Per Share	$0.48
Equity (Book Value)	18.56M
Book Value Per Share	0.44
Working Capital	18.88M

Cash Flow

Operating Cash Flow	-18.47M
Capital Expenditures	n/a
Depreciation & Amortization	45,046
Net Borrowing	-96,501
Free Cash Flow	-18.47M
FCF Per Share	-$0.44

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GANX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-44.08%
Shareholder Yield	-44.08%
Earnings Yield	-25.80%
FCF Yield	-23.63%

Analyst Forecast

The average price target for GANX is $7.50, which is 305.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.50
Price Target Difference	305.41%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3